GGrantIndex
← Search

Regional Oncology Research Center (Risk Factors)

$100,000P30FY2025CANIH

Johns Hopkins University, Baltimore MD

Investigators

Linked publications, trials & patents

Trial NCT02989636Trial NCT02516670Trial NCT02491411Trial NCT02489357Trial NCT02029950Trial NCT01935947Trial NCT01870596Trial NCT01783171Trial NCT01757639Trial NCT01578109Trial NCT01349972Trial NCT01349959Trial NCT01330173Trial NCT01264432Trial NCT01207726Trial NCT01207687Trial NCT01139970Trial NCT01132573Trial NCT01061749Trial NCT00971737Trial NCT00963807Trial NCT00899951Trial NCT00899548Trial NCT00898482Trial NCT00897338Trial NCT00897273Trial NCT00847171Trial NCT00795002Trial NCT00727441Trial NCT00673569Trial NCT00670917Trial NCT00660348Trial NCT00641303Trial NCT00641147Trial NCT00631137Trial NCT00616967Trial NCT00602771Trial NCT00588991Trial NCT00566098Trial NCT00524017Trial NCT00499733Trial NCT00499486Trial NCT00493025Trial NCT00492921Trial NCT00489281Trial NCT00478062Trial NCT00478010Trial NCT00471653Trial NCT00470093Trial NCT00469820Trial NCT00445484Trial NCT00433472Trial NCT00425477Trial NCT00407966Trial NCT00401024Trial NCT00389610Trial NCT00387465Trial NCT00381550Trial NCT00373191Trial NCT00369681Trial NCT00368914Trial NCT00363649Trial NCT00361296Trial NCT00356928Trial NCT00354640Trial NCT00343447Trial NCT00336063Trial NCT00334542Trial NCT00324870Trial NCT00313560Trial NCT00311623Trial NCT00305760Trial NCT00303927Trial NCT00293410Trial NCT00293397Trial NCT00293280Trial NCT00290732Trial NCT00287989Trial NCT00287872Trial NCT00281970Trial NCT00281866Trial NCT00278200Trial NCT00278161Trial NCT00278109Trial NCT00276744Trial NCT00276601Trial NCT00276588Trial NCT00274768Trial NCT00265915Trial NCT00265837Trial NCT00262834Trial NCT00258206Trial NCT00258180Trial NCT00255775Trial NCT00255710Trial NCT00245115Trial NCT00244959Trial NCT00242996Trial NCT00238368Trial NCT00238277

Abstract

Project Summary/Abstract This application is being submitted in response to administrative supplements for research leveraging novel data science approaches to address integration of modifiable risk factors on cancer outcomes. Tobacco, alcohol, and cannabis are three commonly used psychoactive substances in the United States, and all are modifiable behavioral risk factors with direct or indirect links to cancer. Critically, these substances are rarely used in isolation. National survey and intensive longitudinal data demonstrate high rates of same-day and same- occasion co-use. Co-use, especially if initiated early in life, may alter patterns of consumption (e.g., smoking more when drinking), exacerbate consequences of each substance, and increase cumulative exposure to carcinogens over the lifetime. Yet, despite the substantial prevalence of co-use of these substances and their associated cancer risk, large datasets collected in real-world settings that allow us to model co-use at high temporal resolution are rare. Traditional analytic models fall short in capturing complex interactions of these behaviors and lack the temporal granularity needed to examine the dynamics in real-world contexts. This project addresses this critical gap by leveraging intensive daily (24-hour) data on tobacco, alcohol, and cannabis use collected over 30-day periods in diverse populations to model the joint, dynamic impact of these cancer-relevant exposures. We will develop data science approaches with state-of-the-art machine learning techniques to identify high-risk co-use patterns, understand their occurrence in daily life, and uncover opportunities for intervention. The findings will support the development of targeted cancer prevention strategies and inform future clinical and public health efforts to mitigate poly-substance use earlier in life and thus reduce downstream cancer risk. The proposal will address two specific aims: Aim 1 will harmonize and integrate five EMA datasets containing reports of tobacco, alcohol, and cannabis use collected over 24-hour periods. This will yield a dataset comprising over 8,000 daily (24-hour) observations from 373 participants, enabling robust temporal modeling of co-use. Aim 2 will use representation learning to learn behavioral embeddings from temporal co-use data. We will apply self- supervised learning, including contrastive and temporal embedding methods, to model time series data on tobacco, alcohol, and cannabis use. We will use these representations to (1) identify latent states and subgroups through clustering, and (2) integrate them with time-varying predictors. As a next step, high-resolution co-use profiles from Aim 2 can inform two translational applications: (1) Temporal patterns of tobacco, alcohol, and cannabis use can identify which substance to prioritize for intervention to most effectively reduce cancer-relevant exposure, based on frequency, context, and sequence. (2) Our fine-grained EMA data can be leveraged in AI models to impute co-use patterns in large datasets (e.g., PATH, All of Us) using demographic, substance use, and other data, which will enable broader cancer prevention modeling at the population level.

View original record on NIH RePORTER →